Survey of USAF flight surgeons regarding clinical preventive services, using CHD as an indicator

Aviation Space and Environmental Medicine

Volumn 70, Issue 10, 1999, Pages 1029-1037

  Lavallee, Philip J ^a,b   Fonseca, Vincent P ^b  

^a USAF School of Aerospace Medicine ^*  (United States)

^b USAF   (United States)

Author keywords

CHD; Cholesterol; Diet; Exercise; HDL; Medical education

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN;

AIR FORCE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; DIET; DYSLIPIDEMIA; EXERCISE; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MILITARY MEDICINE; OBESITY; PATIENT COUNSELING; PREVENTIVE MEDICINE; PRIMARY HEALTH CARE; REVIEW;

AEROSPACE MEDICINE; ATTITUDE OF HEALTH PERSONNEL; CORONARY DISEASE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MEDICAL STAFF; MILITARY MEDICINE; PHYSICIAN'S PRACTICE PATTERNS; PREVENTIVE HEALTH SERVICES; QUESTIONNAIRES; RISK FACTORS; TOTAL QUALITY MANAGEMENT; UNITED STATES;

EID: 0033373607     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Ahmed SM, Clasen ME, Donnelly JF. Management of dyslipidemia in adults. Am Fam Physician 1998; 57:2192-204.
2. Air Force Instruction 48-123. Medical standards for physical examinations. Washington, DC: U S Government Printing Office; November 1994; para A 6:28.
3. Air Force Pamphlet 48-132. Medical waivers for aircrew. Washington, DC: US Government Printing Office; August 1993; 35-6.
4. Barnard RJ. Effects of life-style modification on serum lipids. Arch Intern Med 1991; 151:1389-94.
5. Beard CM, Barnard RJ, Robbins DC, et al. Effects of diet and exercise on qualitative and quantitative measures of LDL and its susceptibility to oxidation. Arterioscler Thromb Vasc Biol 1996; 16:201-7.
6. Becque MD, Katch VL, Rocchini AP, et al. Coronary risk incidence of obese adolescents: reduction by exercise plus diet intervention. Pediatrics 1988; 81:605-12.
7. Brownson RC, Remington PL, Davis JR, ed. Chronic disease epidemiology and control. Washington, DC: American Public Health Association; 1993.
8. Castelli WP, Anderson K. A population at risk: prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Am J Med 1986; 80(2A):23-32.
9. CDC. Chronic Disease Reports. Coronary heart disease mortality -United States, 1986. MMWR 1989; 38:285-8.
10. CDC. Hospitalization rates for ischemic heart disease - United States, 1970-1986; MMWR 1989; 38:275-84.
11. CDC. Update: prevalence of overweight among children, adolescents, and adults - United States, 1988-1994. MMWR 1997; 46:199-202.
12. Dalessandri KM, Organ CH. Surgery, drugs, lifestyle, and hyperlipidemia. Am J Surg 1995; 169:374-8.
13. Dean AG, Dean JA, Coulombier D, et al. Epi Info, Version 6. a word processing, database, and statistics program for epidemiology on microcomputers. Atlanta, GA: Centers for Disease Control and Prevention, 1994.
14. Department of Defense. Clinical preventive services: quality management review. Rockville, MD: DoD; Feb 1996.
15. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA 1998; 279:1615-22.
16. Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea. JAMA 1953; 152: 1090-3.
17. Findlay IN, Taylor RS, Dargie HJ, et al. Cardiovascular effects of training for a marathon run in unfit middle-aged men. Br J Med 1987; 295:521-4.
18. Friend T. Ornish program is proven to reduce heart disease, its cost. USA Today 1997 Feb 12; sect 1A(col 2).
19. Fripp RR, Hodgson JL. Effect of resistive training on plasma lipid and lipoprotein levels in male adolescents. J Pediatr 1987; 111:926-31.
20. Funk D. The health-care quandary: forty-one medical facilities face possible cutbacks. Air Force Times. Springfield, VA: Army Times Publishing Co; 1997 Dec 8; sect 3A(coll).
21. Glueck CJ. Nonpharmacologic and pharmacologic alteration of high-density lipoprotein cholesterol: therapeutic approaches to prevention of atherosclerosis. Am Heart J 1987; 295:521-4.
22. Gotto AM Jr. Interactions of the major risk factors for coronary heart disease. Am J Med 1986; 80(2A):48-55.
23. Goldberg L, Elliot DL, Schutz RW, Kloster FE. Changes in lipid and lipoprotein levels after weight training. JAMA 1984; 252: 504-6.
24. Grundy SM. Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N Engl J Med 1986; 314:745-8.
25. Grundy SM, Goodman DS, Rifkind BM, Cleeman JI. The place of HDL in cholesterol management. A perspective from the National Cholesterol Education Program. Arch Intern Med 1989; 149:505-10.
26. Herbert PN, Bernier DN, Cullinane EM, et al. High-density lipoprotein metabolism in runners and sedentary men. JAMA 1984; 252:1034-7.
27. Jackson RL, Kashyap ML, Barnhart RL, et al. Influence of polyunsaturated and saturated fats on plasma lipids and lipoproteins in man. Am J Clin Nutr 1984; 39:589-597.
28. Johnson CC, Stone MH, Lopez A, et al. Diet and exercise in middle-aged men. J Am Diet Assoc 1982; 81:695-701.
29. Kannel WB, Eaker ED. Psychosocial and other features of coronary heart disease: insights from the Framingham Study. Am Heart J 1986; 112:2066-73.
30. Kromhout D. Diet-heart issues in a pharmacological era. Lancet 1996; 348:s20-s22.
31. Kruyer WB. Primary prevention of coronary heart disease in cardiopulmonary aspects of aviation medicine. Neuilly-Sur-Seine, France: AGARD-LS-189, 1993; 4-1 to 4-6.
32. Larose S. Hyperlipidemia control program helps HMO members avoid bypasses and angioplasty. Inside Preventive Care, An Aspen Publication 1996; 2:1-3.
33. Leis HP. The relationship of diet to cancer, cardiovascular disease and longevity. Int Surg 1991; 76:1-5.
34. Levy RI. Cholesterol and coronary artery disease. What do clinicians do now? Am J Med 1987; 80(2A):18-22.
35. Lipids Research Clinics Program. The lipid research clinics coronary primary preventive trial results: I. Reduction in incidence of coronary heart disease. JAMA 1984; 251:351-64.
36. Lipids Research Clinics Program. The lipid research clinics coronary primary preventive trial results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol. JAMA 1984; 251:365-74.
37. Little P, Margetts B. The importance of diet and physical activity in the treatment of conditions managed in general practice. Br J Gen Pract 1996; 46:187-92.
38. Matthews W. The end of a promise. Air Force Times, Springfield, VA: Army Times Publishing Co; 1996 Dec 2; sect 3A(col 1).
39. McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA 1993; 270:2207-12.
40. McNamara JJ, Molot MA, Stremple JF, Cutting RT. Coronary artery disease in combat casualties in Vietnam. JAMA 1971; 216:1185-7.
41. Motoyama M, Sunami Y, Kinoshita F, et al. The effects of long-term low intensity aerobic training and detraining on serum lipid and lipoprotein concentrations in elderly men and women. Eur J Appl Physiol 1995; 70:126-31.
42. Multiple Risk Factor Intervention Trial Research Group. Coronary heart disease death, nonfatal acute myocardial infarction, and other clinical outcomes in the multiple risk factor intervention trial. Am J Cardiol 1986; 58:1-13.
43. National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult treatment paned II). Bethesda, MD: National Cholesterol Education Program, National Institutes of Health, National Heart, Lung, and Blood Institute, 1993; DHSS publication no. (NIH)93-3095:5.
44. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990; 336:129-33.
45. Ornish D. Avoiding revascularization with lifestyle changes: the Multicenter Lifestyle Demonstration Project. Am J Cardiol 1998; 82:72T-76T.
46. Ornish D, Scherwitz LW, Billings JH, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998; 280:2001-7.
47. Osswald S, Miles R, Nixon W, Celio P. Review of cardiac events in USAF aviators. Aviat Space Environ Med 1996; 67:1023-7.
48. Paffenbarger RS Jr, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 1978; 108:889-903.
49. Quig DW, Thye FW, Ritchey SJ, et al. Effects of short-term aerobic conditioning and high cholesterol feeding on plasma total and lipoprotein cholesterol levels in sedentary young men. Am J Clin Nutr 1983; 38:825-34.
50. Rauramaa R, Salonen JT, Seppanen K, et al. Effects of mild physical exercise on serum lipoproteins and metabolites of arachidonic acid: a controlled randomised trial in middle-aged men. Br J Med 1984; 288:603-6.
51. Rogers MA, Yamamoto C, Hagberg JM, et al. The effect of seven years of intense exercise training on patients with coronary artery disease. J Am. Coll Cardiol 1987; 10:321-6.
52. Rosenthal MB, Barnard RJ, Rose DP, et al. Effects of a high-complex-carbohydrate, low-fat, low-cholesterol diet on levels of serum lipids and estradiol. Am J Med 1985; 78:23-7.
53. Rubinstein A, Burstein R, Lubin F, et al. Lipoprotein profile changes during intense training of Israeli military recruits. Med Sci Sports Exerc 1995; 27:480-4.
54. Schuler G, Hambrecht R, Schlierf G, et al. Regular physical exercise and low-fat diet - effects on progression of coronary artery disease. Circulation 1992; 86:1-11.
55. Singh RB, Sharma VK, Gupta RK, Singh R. Nutritional modulators of lipoprotein metabolism in patients with risk factors for coronary heart disease: diet and moderate exercise trial. J Am Coll Nutr 1992; 11:391-8.
56. (NCEP). Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993; 269:3015-23.
57. Superko HR, Krauss RM. Coronary artery disease regression: convincing evidence for the benefit of aggressive lipoprotein management. Circulation 1994; 90:1056-69.
58. The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary artery bypass grafts. N Engl J Med 1997; 336:153-62.
59. U.S. Preventive Services Task Force. Guide to clinical preventive services, 2nd ed. Baltimore: Williams and Wilkins, 1996.
60. Whitton RC. Flight surgeons's guide. USAF School of Aerosp Med at Brooks AFB, TX. January 1992; para 10-9.
61. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease II. JAMA 1988; 260:2259-63.